Finance

Beta
Lists
NRIX:NASDAQ
Nurix Therapeutics Inc
US$ २३.८५
+३.७९%
(+०.८७) 1D
US$ २३.८५
०.००% (०.००)
After hours
Closed: जुलाई १५, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRIX...
Open
US$ २२.८५
High
US$ २३.९५
Low
US$ २२.४९
Mkt. cap
२.४८ अरब
Avg. vol.
३०.३९ लाख
Volume
१०.८७ लाख
52-wk high
US$ २५.०८
52-wk low
US$ ८.२०
EPS
-US$ ३.४५
Beta
१.८०
Shares outstanding
१०.३८ करोड
No. of employees
३१७
Open
US$ २२.८५
High
US$ २३.९५
Low
US$ २२.४९
Mkt. cap
२.४८ अरब
Avg. vol.
३०.३९ लाख
Volume
१०.८७ लाख
52-wk high
US$ २५.०८
52-wk low
US$ ८.२०
EPS
-US$ ३.४५
Beta
१.८०
Shares outstanding
१०.३८ करोड
No. of employees
३१७
News stories
From sources across the web
About Nurix Therapeutics Inc
CEO-
Employees३१७
Founded२००९
HeadquartersBrisbane, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitenurixtx.com
Analyst ratings
Based on 13 analysts giving stock ratings to NRIX in the past 3 months
Strong buy
Buy
12
Hold
1
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for NRIX in the last 3 months.
Highest
Current US$ २३.८५
US$ ४५.०० (+८८.६८%)
Average
US$ ३४.१७ (+४३.२७%)
Lowest
US$ २५.०० (+४.८२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Derek Archila
Wells Fargo
Hold
Maintained
US$ २५.००
+४.८%
07/14/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
US$ ३४.००
+४२.६%
07/13/2026
Kostas Biliouris
Oppenheimer
Buy
Maintained
US$ २८.००
+१७.४%
07/10/2026
Brian Abrahams
RBC Capital
Buy
Reiterated
US$ ३३.००
+३८.४%
07/09/2026
Nevin Varghese
RBC Capital
Buy
Reiterated
US$ ३३.००
+३८.४%
07/09/2026
Stephen Willey
Stifel Nicolaus
Buy
Reiterated
US$ ४०.००
+६७.७%
07/10/2026
Gregory Renza
Truist Financial
Buy
Reiterated
US$ ३४.००
+४२.६%
07/10/2026
Gil Blum
Needham
Buy
Maintained
US$ ३४.००
+४२.६%
07/10/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$ ३४.००
+४२.६%
07/10/2026
Roger Song
Jefferies
Buy
Maintained
US$ ४५.००
+८८.७%
07/08/2026
Jeet Mukherjee
BTIG
Buy
Reiterated
US$ ३२.००
+३४.२%
07/01/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
-
-
06/11/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
US$ ३६.००
+५०.९%
06/08/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
US$ २८.००
+१७.४%
05/13/2026
Biren Amin
Piper Sandler
Buy
Maintained
US$ ३५.००
+४६.८%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ अगस्ट
२०२५ नोभेम्बर
२०२६ फेब्रुअरी
२०२६ मे
Revenue
७८.९४ लाख
१.३६ करोड
६२.५२ लाख
९०.४३ लाख
Cost of goods sold
८.६१ करोड
८.३० करोड
८.४१ करोड
८.७७ करोड
Cost of revenue
८.६१ करोड
८.३० करोड
८.४१ करोड
८.७७ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.३२ करोड
१.३६ करोड
१.४६ करोड
१.५६ करोड
Operating expense
१.३२ करोड
१.३६ करोड
१.४६ करोड
१.५६ करोड
Total operating expenses
९.९३ करोड
९.६७ करोड
९.८७ करोड
१०.३२ करोड
Operating income
-९.१४ करोड
-८.३१ करोड
-९.२५ करोड
-९.४२ करोड
Other non operating income
-
-
-
-
EBT including unusual items
-८.६४ करोड
-७.८२ करोड
-८.७२ करोड
-८.९८ करोड
EBT excluding unusual items
-८.६४ करोड
-७.८२ करोड
-८.७२ करोड
-८.९८ करोड
Income tax expense
-
-
-
-२.७१ लाख
Effective tax rate
-
-
-
०.३०%
Other operating expenses
-
-
-
-
Net income
-८.६४ करोड
-७.८२ करोड
-८.७२ करोड
-८.९५ करोड
Net profit margin
-१,०९४.७७%
-५७६.१३%
-१,३९४.३४%
-९९०.१०%
Earnings per share
-१.०३
-०.८२
-०.७९
-०.८१
Interest and investment income
४९.६४ लाख
४८.७४ लाख
५३.२१ लाख
४३.९८ लाख
Interest expense
-
-
-
-
Net interest expenses
४९.६४ लाख
४८.७४ लाख
५३.२१ लाख
४३.९८ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-८.९४ करोड
-८.१६ करोड
-९.०३ करोड
-९.१९ करोड
Gain or loss from assets sale
-
८९.०० हजार
१.६० लाख
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer